Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. [electronic resource]
Producer: 20050103Description: 3171-5 p. digitalISSN:- 1524-4539
- Adenosine Diphosphate -- antagonists & inhibitors
- Aged
- Aspirin -- administration & dosage
- Biotransformation
- Clopidogrel
- Combined Modality Therapy
- Coronary Artery Disease -- complications
- Coronary Restenosis -- epidemiology
- Coronary Thrombosis -- epidemiology
- Drug Resistance
- Drug Therapy, Combination
- Epinephrine -- administration & dosage
- Eptifibatide
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- drug therapy
- Peptides -- therapeutic use
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- pharmacology
- Prodrugs -- pharmacology
- Prospective Studies
- Purinergic P2 Receptor Antagonists
- Recurrence
- Risk
- Smoking -- epidemiology
- Stents
- Ticlopidine -- analogs & derivatives
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.